Brightsurf Science News & Current Events

September 16, 2012
Symposium to showcase use of open-access biodiversity data in science
A public symposium in Norway this week will showcase the benefits to scientific research of more than a decade's investment in free, open access to large volumes of data on the occurrence of species over time and across the planet.

Most coral reefs are at risk unless climate change is drastically limited
Coral reefs face severe challenges even if global warming is restricted to the two degrees Celsius commonly perceived as safe for many natural and man-made systems.

Researchers identify mechanism that leads to diabetes, blindness
The rare disorder Wolfram syndrome is caused by mutations in a single gene, but its effects on the body are far reaching.

Chemists develop reversible method of tagging proteins
Chemists at UC San Diego have developed a method that for the first time provides scientists the ability to attach chemical probes onto proteins and subsequently remove them in a repeatable cycle.

Biggest European health study identifies key priorities in 26 cities
Researchers have announced the results of the largest ever health and lifestyle survey of cities and conurbations across Europe - including five British urban centers.

How bees decide what to be
Johns Hopkins scientists report what is believed to be the first evidence that complex, reversible behavioral patterns in bees - and presumably other animals - are linked to reversible chemical tags on genes.

Young researcher on the trail of herbal snakebite antidote
A Ph.D. student at the University of Copenhagen has drawn on nature's own pharmacy to help improve the treatment of snakebites in Africa.

Chinese scientists discover MVK mutations associated with DSAP
Chinese scientists discover MVK mutations associated with DSAP.

Drug combination against NRAS-mutant melanoma discovered
A new study published online in Nature Medicine, describes the discovery of a novel drug combination aimed at a patients with NRAS-mutant melanoma, who currently have no effective therapeutic options.

Flu antibody's 'one-handed grab' may boost effort toward universal vaccine, new therapies
Scientists from The Scripps Research Institute and Sea Lane Biotechnologies have solved the co-crystal structure of a human antibody that can neutralize a broad range of influenza viruses in a unique way. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to